Acelyrin Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Acelyrin Inc 's ROA in the first quarter of 2025?
Acelyrin Inc recorded a cumulative net loss of $-269 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -48.87%.

However, within the Healthcare sector 606 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 4137, from total ROA ranking in the fourth quarter of 2024 at 4667.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Total Assets Change	-37.42 %	-34.22 %	-22.76 %	-21.96 %	133.65 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-269	-248	-264	-300	-240
Return On Assets (TTM)	-48.87 %	-40.38 %	-38.97 %	-41.4 %	-31.19 %
SLRN's Total Ranking	# 4137	# 4667	# 4099	# 4167	# 4025
Total Assets (TTM) in million	437	491	618	652	697
Seq. Total Assets Change	-11.12 %	-20.57 %	-5.13 %	-6.56 %	-6.59 %
Seq. Net Income Change	-	-	-	-	-

SLRN's 5 Years Annual ROA >> Back to SLRN Management Effectiveness >> Compare SLRN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 272
Sector	# 607
Overall	# 4084

Return On Assets Statistics
High	Average	Low
-31.23 %	-43 %	-57.03 %
(Mar 31 2024)		(Dec 31 2023)

Financial Statements
Acelyrin Inc 's Assets	$ 437 million	SLRN's Balance sheet
Acelyrin Inc 's Income	$ -55 million	Quarterly SLRN's Income Statement
SLRN's Income by Division		See SLRN's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	FY	FY	FY
Y / Y Total Assets Change	-33.87 %	-	-	-	-
Total Assets in million	491	743	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-248	-382	0	0	0
Annual Return On Assets	-50.54 %	-51.39 %	-	-	-

SLRN's 5 Years Annual ROA >> Back to SLRN Management Effectiveness >> Compare SLRN ROA to its Competitors

More Return On Assets Ratios
SLRN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SLRN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SLRN's Competitors
Subscribers only: Roa for Acelyrin Inc 's Suppliers
Subscribers only: Return On Assets for SLRN's Customers

You may also want to know
SLRN's Roi	SLRN's Inventory Turnover Ratio	SLRN's Growth Rates	SLRN's Dividend Comparisons
	SLRN's Profitability Ratios	SLRN's Asset Turnover Ratio	SLRN's Dividend Growth
SLRN's Roe	SLRN's Valuation Ratios	SLRN's Financial Strength Ratios	SLRN's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:48:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.